WASHINGTON (AP) - President Barack Obama on Tuesday proposed to "once and for all" close the detention center at Guantanamo Bay, Cuba, and transfer remaining detainees to a facility in the U.S., though his plan does not specify where.
Rufus Roberts, 83 of Oxford, passed away February 17, 2016. Mr. Roberts was of the Baptist faith. He loved going fishing, vegetable gardening and camping in the mountains. In addition, he enjoyed football and stock car racing. Mr. Roberts never had biological children of his own, but was a father and grandfather to many. He was preceded in death by two wives, Edna Dalton Roberts, and Pat Moody; parents, Jessie McCord and Lucy Gary Roberts; sister, Inez Johnson; brother, Grady Roberts.
STUTTGART, Ark. (AP) - A Georgia man accused of beating a deer with an accounting textbook after it had been hit along an Arkansas highway has been charged with a misdemeanor count of cruelty to animals and wasting wildlife and set for a court appearance later this month.
COLUMBIA, S.C. (AP) - Republican Sen. Rand Paul dropped his 2016 campaign for president Wednesday, eclipsed by other candidates who kept his base of support from growing into a viable force in the crowded 2016 field.
PUNXSUTAWNEY, Pa. (AP) - The handlers of Pennsylvania's most famous groundhog, Punxsutawney Phil, said the furry rodent failed to see his shadow at dawn Tuesday, meaning he "predicted" an early spring.
Deanna Franklin of Covington, passed away January 24, 2016, at the age of 52. Deanna was a faithful member of Canaan Baptist Church and loved her church family dearly. She was a 1611 KJV Bible-believing, missions-minded Christian lady who loved presenting the Gospel and sharing Christ with others. She was a dedicated employee of AT&T for 31 years. Deanna always put others before herself, and will undoubtedly be missed by all who knew and loved her. She was preceded in death by her father, Doyle Hensdill.
TRENTON, N.J. (AP) - Irish drugmaker Shire PLC's second attempt to buy Baxalta looks more likely to succeed, with Baxalta's board backing the sweetened offer of $32 billion in cash and stock. If the deal goes through, the combined company would be one of the world's top 20 drugmakers by revenue and a leader in the sizzling niche of rare disease medicines.